Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.78 USD
Change Today +0.54 / 4.80%
Volume 253.8K
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

brooks automation inc (BRKS) Snapshot

Open
$11.36
Previous Close
$11.24
Day High
$11.80
Day Low
$11.36
52 Week High
02/5/15 - $13.48
52 Week Low
06/4/14 - $9.18
Market Cap
794.9M
Average Volume 10 Days
131.7K
EPS TTM
$0.11
Shares Outstanding
67.5M
EX-Date
06/3/15
P/E TM
103.9x
Dividend
$0.40
Dividend Yield
3.23%
Current Stock Chart for BROOKS AUTOMATION INC (BRKS)

brooks automation inc (BRKS) Related Bloomberg News

View More Bloomberg News

brooks automation inc (BRKS) Related Businessweek News

No Related Businessweek News Found

brooks automation inc (BRKS) Details

Brooks Automation, Inc. provides automation and cryogenic solutions for semiconductor manufacturing and life sciences markets. The company’s Brooks Product Solutions segment provides a range of products and solutions that enable enhanced throughput and yield in controlled operating environments. This segment offers atmospheric and vacuum robots, robotic modules, and tool automation systems that provide precision handling and clean wafer environments, as well as vacuum pumping and thermal management solutions used to create and control critical process vacuum applications. Its Brooks Global Services segment provides a range of support services, including repair services, diagnostic support services, and installation services to enable the customers to enhance process tool uptime and productivity. This segment also offers spare parts to end-user customers for the enhancement of customer tool productivity. The company’s Brooks Life Science Systems segment provides automated sample management systems for automated cold sample storage, equipment for sample preparation and handling, consumables, and parts and support services to a range of life science customers, including pharmaceutical companies, biotechnology companies, national laboratories, research institutes, and research hospitals. Brooks Automation, Inc. markets its products through its direct sales organizations in Asia, Europe, the Middle East, and North America. It has a strategic collaboration agreement with Chart Industries, Inc. to develop and distribute automated cryogenic storage solutions. The company was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

1,455 Employees
Last Reported Date: 11/13/14
Founded in 1978

brooks automation inc (BRKS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $611.2K
President and Chief Operating Officer
Total Annual Compensation: $479.2K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $415.2K
Chief Strategy & New Business Officer and Sen...
Total Annual Compensation: $336.9K
Senior Vice President of Human Resources
Total Annual Compensation: $257.2K
Compensation as of Fiscal Year 2014.

brooks automation inc (BRKS) Key Developments

Brooks Automation, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2015; Provides Earnings Guidance for the Third Quarter of 2015; Declares Dividend, Payable on June 26, 2015

Brooks Automation, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended March 31, 2015. For the quarter, the company reported total revenue of $139,313,000 compared to $125,900,000 a year ago. Operating income was $3,053,000 compared to $2,396,000 a year ago. Income before income taxes and equity in earnings of equity method investments was $4,344,000 compared to $2,710,000 a year ago. Income from continuing operations was $2,711,000 or $0.04 per basic and diluted share compared to $2,103,000 or $0.03 per basic and diluted share a year ago. Net income attributable to the company was $2,711,000 or $0.04 per basic and diluted share compared to $3,189,000 or $0.05 per basic and diluted share a year ago. Non-GAAP net income attributable to the company was $5,429,000 or $0.08 per diluted share compared to $4,337,000 or $0.06 per diluted share a year ago. Non-GAAP net income attributable to the company – excluding stock based information was $9,054,000 or $0.13 per diluted share compared to $8,132,000 or $0.12 per diluted share a year ago. EBITDA was $10,471,000 compared to $9,428,000 a year ago. Adjusted EBITDA was $14,845,000 compared to $13,136,000 a year ago. Operating cash flow was $1.9 million. Revenue increased 14% sequentially driven by a 19% increase in Brooks Product Solutions revenue and a 5% increase in Life Sciences revenue. For the six months, the company reported total revenue of $262,049,000 compared to $242,972,000 a year ago. Operating loss was $3,427,000 compared to operating income of $3,854,000 a year ago. Loss before income taxes and equity in earnings of equity method investments was $968,000 compared to income before income taxes and equity in earnings of equity method investments of $4,673,000 a year ago. Loss from continuing operations was $23,000 compared to income from continuing operations of $4,022,000 a year ago. Net loss attributable to the company was $23,000 compared to net income attributable to the company of $6,637,000 a year ago. Net cash provided by operating activities was $4,953,000 compared to $35,651,000 a year ago. Purchases of property, plant and equipment were $3,647,000 compared to $2,696,000 a year ago. Non-GAAP net income attributable to the company was $8,872,000 or $0.13 per diluted share compared to $8,838,000 or $0.13 per diluted share a year ago. Non-GAAP net income attributable to the company – excluding stock based information was $15,980,000 or $0.24 per diluted share compared to $15,356,000 or $0.23 per diluted share a year ago. EBITDA was $10,880,000 compared to $19,085,000 a year ago. Adjusted EBITDA was $23,922,000 compared to $25,314,000 a year ago. The company announced revenue and earnings guidance for the third quarter of fiscal 2015. Revenue is expected to be in the range of $136 million to $142 million. Non-GAAP diluted earnings per share is expected to be in the range of $0.08 to $0.12. The company announced that the Board of Directors has reiterated a dividend of $0.10 per share payable on June 26, 2015 to stockholders of record on June 5, 2015. Future dividend declarations, as well as the record and payment dates for such dividends, are subject to the final determination of the company's Board of Directors.

Brooks Automation, Inc. Introduces BioStore III Cryo Automated Cryogenic Sample Management System

Brooks Automation, Inc. announced the introduction of the BioStore III Cryo, an automated cryogenic sample management system. BioStore III Cryo introduces automation to the large segment of bio-samples being stored, which currently relies on manual cryo storage systems. BioStore III Cryo incorporates sample monitoring, tracking, and inventory control with the industry's standard cryo storage vessel. The system can access virtually any type of sample within a cryobox format and retrieve a box of samples in less than 60 seconds. Meanwhile, the other samples stored within the liquid nitrogen system are maintained at a temperature below -135° C at all times. The highly ergonomic design and built-in user safety features of the BioStore III Cryo system provide new and significant benefits over traditional, manual cryo storage systems.

BioCision, LLC and Brooks Automation, Inc. Announce Joint Development Partnership to Unveil New Cryogenic Sample Handling and Transport Product

BioCision, LLC and Brooks Automation announced their collaborative research and development agreement to improve the handling and transport of valuable biospecimens stored in liquid nitrogen is progressing to the commercialization stage. The co-development project between BioCision and Brooks began in mid-2014 with the goal of providing tools that enable more rigorous collection, handling, and transporting of temperature-sensitive specimens and therapeutics. Current methods, including placing samples stored at liquid nitrogen temperature (-196 C) onto dry ice, which is considerably higher in temperature at -78 C, or utilizing makeshift transporters such as pans with loose liquid nitrogen, leave samples vulnerable to drastic temperature shifts and potentially place operators at risk with insufficient safeguards in place for handling loose liquid nitrogen. The result of this collaboration will be revealed at the upcoming 2015 meeting of the International Society for Biological and Environmental Repositories (ISBER).

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRKS:US $11.78 USD +0.54

BRKS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advanced Energy Industries Inc $29.18 USD +0.66
Cabot Microelectronics Corp $46.59 USD +0.41
Daihen Corp ¥635.00 JPY -10.00
Inficon Holding AG SFr.336.75 CHF +1.25
Photronics Inc $10.08 USD -0.01
View Industry Companies
 

Industry Analysis

BRKS

Industry Average

Valuation BRKS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.5x
Price/Book 1.1x
Price/Cash Flow 30.7x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BROOKS AUTOMATION INC, please visit www.brooks.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.